{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:41:16Z","timestamp":1792784476689,"version":"4.5.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIRAP"},{"name":"ARC"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.vaccine.2013.08.020","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T09:30:40Z","timestamp":1377163840000},"page":"1563-1571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Development status and future prospects for a vaccine against Chlamydia trachomatis infection"],"prefix":"10.1016","volume":"32","author":[{"given":"Louise M.","family":"Hafner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Timms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.08.020_bib0005","series-title":"Ectopic pregnancy \u2013 modern diagnosis and management","article-title":"Tubal damage, infertility and tubal ectopic pregnancy: Chlamydia trachomatis and other microbial aetiologies","author":"Hafner","year":"2011"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0010","series-title":"Global prevalence and incidence of selected curable sexually transmitted infections","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0015","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0020","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/OLQ.0b013e3181d73e4c","article-title":"The direct cost of chlamydial infections: estimates for the employer-sponsored privately insured population in the United States, 2003\u20132007","volume":"37","author":"Owusu-Edusei","year":"2010","journal-title":"Sex Transm Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.08.020_bib0025","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1086\/652395","article-title":"Risk of sequelae after Chlamydia trachomatis genital infection in women","volume":"201","author":"Haggerty","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archpedi.157.6.565","article-title":"Oral erythromycin prophylaxis vs watchful waiting in caring for newborns exposed to Chlamydia trachomatis","volume":"157","author":"Rosenman","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0035","series-title":"Vaccines for the 21st century: a tool for decisionmaking","author":"Institute of Medicine (US) Committee to Study Priorities for Vaccine Development","year":"2000"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0040","first-page":"873","article-title":"Diagnosis and treatment of urethritis in men","volume":"81","author":"Brill","year":"2010","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0045","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/OLQ.0b013e3182040de9","article-title":"Demographic, behavioral, and clinical characteristics of men with nongonococcal urethritis differ by etiology: a case-comparison study","volume":"38","author":"Wetmore","year":"2011","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ucl.2007.09.013","article-title":"Diagnosis and management of epididymitis","volume":"35","author":"Tracy","year":"2008","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0055","first-page":"16","article-title":"Prevalence of chlamydial infection in acute epididymo-orchitis","volume":"63","author":"Mulcahy","year":"1987","journal-title":"Genitourin Med"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0060","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/infdis\/154.5.900","article-title":"Asymptomatic Chlamydia trachomatis infections among sexually active men","volume":"154","author":"Karam","year":"1986","journal-title":"J Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.08.020_bib0065","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1086\/513844","article-title":"Chlamydia trachomatis infections: progress and problems","volume":"179","author":"Stamm","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0070","first-page":"595","article-title":"Lymphogranuloma venereum","volume":"4","author":"Stamm","year":"2008","journal-title":"Sexually transmitted diseases"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0075","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.vaccine.2013.07.087","article-title":"Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines","volume":"32","author":"Gottlieb","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/sti.2005.017517","article-title":"Chlamydia screening studies G. Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling","volume":"82","author":"Roberts","year":"2006","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2458-6-106","article-title":"Does population screening for Chlamydia trachomatis raise anxiety among those tested? Findings from a population based chlamydia screening study","volume":"6","author":"Campbell","year":"2006","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11080","article-title":"Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection","volume":"11","author":"Low","year":"2007","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0095","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1471-2334-11-211","article-title":"Efficacy of interventions to increase the uptake of chlamydia screening in primary care: a systematic review","volume":"11","author":"Guy","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5694\/j.1326-5377.2011.tb02957.x","article-title":"Australian general practitioner chlamydia testing rates among young people","volume":"194","author":"Kong","year":"2011","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0105","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/OLQ.0b013e318254c837","article-title":"Self-reported Chlamydia testing rates of sexually active women aged 15\u201325 years in the United States, 2006\u20132008","volume":"39","author":"Tao","year":"2012","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0110","doi-asserted-by":"crossref","first-page":"c7250","DOI":"10.1136\/bmj.c7250","article-title":"Costs and cost effectiveness of different strategies for chlamydia screening and partner notification: an economic and mathematical modelling study","volume":"342","author":"Turner","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1086\/589883","article-title":"Coverage is the key for effective screening of Chlamydia trachomatis in Australia","volume":"198","author":"Regan","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-4682-3-3","article-title":"Developing a realistic sexual network model of chlamydia transmission in Britain","volume":"3","author":"Turner","year":"2006","journal-title":"Theor Bio Med Model"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0125","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/sti.2005.019067","article-title":"Modelling the effectiveness of chlamydia screening in England","volume":"82","author":"Turner","year":"2006","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0130","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa041681","article-title":"Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection","volume":"352","author":"Golden","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0135","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00007435-200209000-00001","article-title":"Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials","volume":"29","author":"Lau","year":"2002","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0140","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/cid\/ciq074","article-title":"Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens\u2014a randomized clinical trial","volume":"52","author":"Schwebke","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0145","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/sti.2006.022053","article-title":"Incidence and reinfection rates of genital chlamydial infection among women aged 16\u201324 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group","volume":"83","author":"LaMontagne","year":"2007","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0150","doi-asserted-by":"crossref","first-page":"e37778","DOI":"10.1371\/journal.pone.0037778","article-title":"Chlamydia trachomatis incidence and re-infection among young women\u2014behavioural and microbiological characteristics","volume":"7","author":"Walker","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0155","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1086\/497341","article-title":"The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection","volume":"192","author":"Brunham","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0160","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/aji.12008","article-title":"Transient detection of chlamydial-specific Th1 memory cells in the peripheral circulation of women with history of Chlamydia trachomatis genital tract infection","volume":"68","author":"Vicetti Miguel","year":"2012","journal-title":"Am J Reprod Immunol"},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2013.08.020_bib0165","doi-asserted-by":"crossref","first-page":"F149","DOI":"10.1016\/j.vaccine.2012.04.107","article-title":"Understanding human papillomavirus vaccine uptake","volume":"30","author":"Fisher","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0170","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1016\/j.vaccine.2012.03.063","article-title":"Factors associated with HPV vaccine uptake in teenage girls: a systematic review","volume":"30","author":"Kessels","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0175","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.femsre.2005.03.002","article-title":"The chlamydial developmental cycle","volume":"29","author":"Abdelrahman","year":"2005","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/oxfordjournals.bmb.a071800","article-title":"Chlamydial classification, development and structure","volume":"39","author":"Ward","year":"1983","journal-title":"Br Med Bull"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0185","series-title":"Sexually transmitted diseases","first-page":"555","article-title":"Biology of Chlamydia trachomatis","author":"Schachter","year":"2008"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrmicro1821","article-title":"Exit strategies of intracellular pathogens","volume":"6","author":"Hybiske","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0195","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.micinf.2011.03.004","article-title":"Chlamydia persistence\u2014a tool to dissect chlamydia\u2013host interactions","volume":"13","author":"Schoborg","year":"2011","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/jac\/dkh283","article-title":"Pre-exposure of infected human endometrial epithelial cells to penicillin in vitro renders Chlamydia trachomatis refractory to azithromycin","volume":"54","author":"Wyrick","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.08.020_bib0205","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1086\/652402","article-title":"Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies","volume":"201","author":"Geisler","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0210","series-title":"Chlamydia sexually transmitted diseases: vaccines, prevention, and control","first-page":"369","author":"Hafner","year":"2013"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0215","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1615\/CritRevImmunol.v29.i4.10","article-title":"Chlamydial infection of immune cells: altered function and implications for disease","volume":"29","author":"Beagley","year":"2009","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0220","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1128\/IAI.01313-07","article-title":"Intracellular interleukin-1alpha mediates interleukin-8 production induced by Chlamydia trachomatis infection via a mechanism independent of type I interleukin-1 receptor","volume":"76","author":"Cheng","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0225","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jri.2011.01.005","article-title":"Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections","volume":"88","author":"Hickey","year":"2011","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0230","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1172\/JCI119136","article-title":"Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis","volume":"99","author":"Rasmussen","year":"1997","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.vaccine.2013.08.020_bib0235","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2249.2007.03357.x","article-title":"Mucosal and peripheral immune responses to chlamydial heat shock proteins in women infected with Chlamydia trachomatis","volume":"148","author":"Agrawal","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0240","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/infdis\/jis621","article-title":"Immunoglobulin-specific responses to Chlamydia elementary bodies in individuals with and at risk for genital chlamydial infection","volume":"206","author":"Geisler","year":"2012","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2013.08.020_bib0245","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1365-2249.2003.02163.x","article-title":"Mucosal and systemic immune responses to plasmid protein pgp3 in patients with genital and ocular Chlamydia trachomatis infection","volume":"132","author":"Ghaem-Maghami","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0250","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a010256","article-title":"Chlamydial intracellular survival strategies","author":"Bastidas","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0255","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2249.2004.02564.x","article-title":"Cytokine expression pattern in the genital tract of C. trachomatis positive infertile women-implication for T cell responses","volume":"137","author":"Reddy","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0260","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0952-7915(02)00361-8","article-title":"The role of IFN-gamma in the outcome of chlamydial infection","volume":"14","author":"Rottenberg","year":"2002","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2013.08.020_bib0265","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri1551","article-title":"Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine","volume":"5","author":"Brunham","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0270","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1073\/pnas.0608393104","article-title":"Cleavage of p65\/RelA of the NF-kB pathway by Chlamydia","volume":"104","author":"Lad","year":"2007","journal-title":"Proc Natl Acad Sci"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.08.020_bib0275","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1128\/IAI.01305-12","article-title":"Chlamydia trachomatis plasmid-encoded Pgp4 is a transcriptional regulator of virulence-associated genes","volume":"81","author":"Song","year":"2013","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2013.08.020_bib0280","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1084\/jem.189.12.1931","article-title":"Chlamydia inhibits interferon \u03b3-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1","volume":"189","author":"Zhong","year":"1999","journal-title":"J Exp Med"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2013.08.020_bib0285","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1084\/jem.191.9.1525","article-title":"Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells","volume":"191","author":"Zhong","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0290","article-title":"Chlamydia trachomatis immune evasion via downregulation of MHC class i surface expression involves direct and indirect mechanisms","volume":"2011","author":"Ibana","year":"2011","journal-title":"Inf Dis Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0295","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/infdis\/jir822","article-title":"Variants in Toll-like receptor 1 and 4 genes are associated with Chlamydia trachomatis among women with pelvic inflammatory disease","volume":"205","author":"Taylor","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0300","series-title":"Sexually transmitted diseases: vaccines, prevention, and control","first-page":"71","article-title":"Mucosal immunity in the human reproductive tract: balancing reproductive potential with protection against sexually transmitted pathogens","author":"Wira","year":"2013"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0305","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1471-0528.1985.tb04874.x","article-title":"The relation between vaginal pH and the microbiological status in vaginitis","volume":"92","author":"Hanna","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0310","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2334-12-33","article-title":"A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection","volume":"12","author":"Clarke","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0315","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.vaccine.2013.10.010","article-title":"Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections","volume":"32","author":"Brotman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0320","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/icb.2009.3","article-title":"Effects of inoculating dose on the kinetics of Chlamydia muridarum genital infection in female mice","volume":"87","author":"Carey","year":"2009","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2013.08.020_bib0325","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0015-0282(97)80079-9","article-title":"The impact of hydrosalpinx on successful pregnancy in tubal factor infertility treated by in vitro fertilization","volume":"67","author":"Blazar","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0330","first-page":"927","article-title":"Pathogenesis of endometritis and salpingitis in a guinea pig model of chlamydial genital infection","volume":"140","author":"Rank","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0335","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1086\/428287","article-title":"The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study","volume":"191","author":"Molano","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0340","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1128\/IAI.58.6.2021-2023.1990","article-title":"Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection","volume":"58","author":"Ito","year":"1990","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0345","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.1073\/pnas.0504198102","article-title":"Chlamydial IFN-gamma immune evasion is linked to host infection tropism","volume":"102","author":"Nelson","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0350","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1128\/IAI.62.9.3705-3711.1994","article-title":"Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence","volume":"62","author":"Beatty","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0355","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.1128\/IAI.68.12.6979-6987.2000","article-title":"Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells","volume":"68","author":"Morrison","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0360","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.4049\/jimmunol.158.7.3344","article-title":"Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways","volume":"158","author":"Perry","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0365","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.1128\/IAI.73.10.6962-6973.2005","article-title":"Expression of matrix metalloproteinases subsequent to urogenital Chlamydia muridarum infection of mice","volume":"73","author":"Ramsey","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0370","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0966-842X(02)00011-2","article-title":"The cellular paradigm of chlamydial pathogenesis","volume":"11","author":"Stephens","year":"2003","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0375","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00007435-199501000-00008","article-title":"Increased incidence of oviduct pathology in the guinea pig after repeat vaginal inoculation with the chlamydial agent of guinea pig inclusion conjunctivitis","volume":"22","author":"Rank","year":"1995","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0380","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1128\/IAI.65.6.2175-2182.1997","article-title":"Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring","volume":"65","author":"Van Voorhis","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0385","doi-asserted-by":"crossref","first-page":"675360","DOI":"10.1155\/2011\/675360","article-title":"Nonhuman primate models used to study pelvic inflammatory disease caused by Chlamydia trachomatis","volume":"2011","author":"Bell","year":"2011","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0390","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/j.vaccine.2011.02.057","article-title":"Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model","volume":"29","author":"Cheng","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0395","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.4049\/jimmunol.0804375","article-title":"Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine","volume":"182","author":"Kari","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0400","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1084\/jem.20111266","article-title":"A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates","volume":"208","author":"Kari","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0405","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/infdis\/jir541","article-title":"The effects of a single cervical inoculation of Chlamydia trachomatis on the female reproductive tract of the baboon (Papio anubis)","volume":"204","author":"Bell","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0410","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/infdis\/155.6.1292","article-title":"Distal tubal obstruction induced by repeated Chlamydia trachomatis salpingeal infections in pig-tailed macaques","volume":"155","author":"Patton","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0415","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0684.2011.00488.x","article-title":"Development of a pigtail macaque model of sexually transmitted infection\/HIV coinfection using Chlamydia trachomatis, Trichomonas vaginalis, and SHIV(SF162P3)","volume":"40","author":"Henning","year":"2011","journal-title":"J Med Primatol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0420","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1084\/jem.115.5.1009","article-title":"The effect of trachoma virus vaccine on the course of experimental trachoma infection in blind human volunteers","volume":"115","author":"Grayston","year":"1962","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0425","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.vaccine.2013.10.016","article-title":"Towards a safe and effective chlamydial vaccine: lessons from the eye","volume":"32","author":"Mabey","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0430","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.1016\/j.vaccine.2011.07.012","article-title":"A comparison of the effects of a chlamydial vaccine administered during or after a C. muridarum urogenital infection of female mice","volume":"29","author":"Carey","year":"2011","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2013.08.020_bib0435","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/infdis\/jit094","article-title":"Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection","volume":"207","author":"Geisler","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0440","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4161\/hv.6.8.12299","article-title":"Development of a Chlamydia trachomatis T cell vaccine","volume":"6","author":"Karunakaran","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0445","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.coi.2012.03.008","article-title":"Adjuvants for human vaccines","volume":"24","author":"Alving","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0450","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1128\/IAI.68.6.3074-3078.2000","article-title":"Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses","volume":"68","author":"Dong-Ji","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0455","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.vaccine.2005.08.074","article-title":"Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge","volume":"24","author":"Pal","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0460","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2567.2007.02608.x","article-title":"Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines","volume":"122","author":"He","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0465","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1574-695X.2006.00165.x","article-title":"A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes","volume":"49","author":"Macmillan","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0470","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1086\/590670","article-title":"Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model","volume":"198","author":"Hansen","year":"2008","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2013.08.020_bib0475","doi-asserted-by":"crossref","first-page":"e61962","DOI":"10.1371\/journal.pone.0061962","article-title":"Immunization with a MOMP-based vaccine protects against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathology","volume":"8","author":"O\u2019Meara","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0480","series-title":"Immunization, vaccines and biologicals","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0485","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0490","first-page":"CD001261","article-title":"Vaccines for preventing typhoid fever","author":"Fraser","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0495","first-page":"CD000974","article-title":"Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected)","author":"Graves","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0500","first-page":"117","volume":"vol. 76","author":"World Health Organization","year":"2001"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0505","first-page":"25","volume":"vol. 79","author":"World Health Organization","year":"2004"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0510","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.vaccine.2013.11.007","article-title":"The theoretical impacts of vaccines that protect against sexually transmitted infections and disease","volume":"32","author":"Garnett","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0515","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.qai.0000230526.79341.83","article-title":"Modeling the impact of a partially effective HIV vaccine on HIV infection and death among women and infants in South Africa","volume":"43","author":"Amirfar","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0520","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1098\/rspb.1995.0129","article-title":"Potential impact of low efficacy HIV-1 vaccines in populations with high rates of infection","volume":"261","author":"Anderson","year":"1995","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0525","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/QAI.0b013e31812506fd","article-title":"Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: a South African example","volume":"46","author":"Andersson","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0530","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1073\/pnas.061029998","article-title":"Live attenuated HIV vaccines: predicting the tradeoff between efficacy and safety","volume":"98","author":"Blower","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0535","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.8073289","article-title":"Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco","volume":"265","author":"Blower","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0540","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1016\/j.vaccine.2007.08.047","article-title":"HIV\/AIDS vaccination in adolescents would be efficient and practical when vaccine supplies are limited","volume":"25","author":"Johnson","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0545","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1097\/QAD.0b013e32833ead96","article-title":"How low can you go: the impact of a modestly effective HIV vaccine compared with male circumcision","volume":"24","author":"Kaldor","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0550","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1098\/rspb.1993.0075","article-title":"Imperfect vaccines and herd immunity to HIV","volume":"253","author":"McLean","year":"1993","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0555","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1016\/j.vaccine.2012.03.065","article-title":"Potential overestimation of HPV vaccine impact due to unmasking of non-vaccine types: quantification using a multi-type mathematical model","volume":"30","author":"Choi","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0560","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ijc.11334","article-title":"A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16\/18 vaccine","volume":"106","author":"Goldie","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0565","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1371\/journal.pmed.0030164","article-title":"Mathematical model of HPV provides insight into impacts of risk factors and vaccine","volume":"3","author":"Kim","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0570","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1016\/j.vaccine.2010.05.056","article-title":"Understanding differences in predictions of HPV vaccine effectiveness: a comparative model-based analysis","volume":"28","author":"Van de Velde","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0575","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1016\/j.vaccine.2011.07.001","article-title":"Modeling the impact of RV144-like vaccines on HIV transmission","volume":"29","author":"Hankins","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0580","series-title":"MIDAS: Models of Infectious Disease Agent Study","year":"2013"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0585","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1098\/rsif.2011.0131","article-title":"Transmission of Chlamydia trachomatis through sexual partnerships: a comparison between three individual-based models and empirical data","volume":"9","author":"Althaus","year":"2012","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0590","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1086\/598983","article-title":"Modeling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection","volume":"199","author":"Gray","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0595","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1084\/jem.20112088","article-title":"Unraveling the basic biology and clinical significance of the chlamydial plasmid","volume":"208","author":"Rockey","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0600","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1128\/IAI.01118-10","article-title":"Toll-like receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C. trachomatis but not by C. muridarum","volume":"79","author":"O\u2018Connell","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0605","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.4049\/jimmunol.179.6.4027","article-title":"Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease","volume":"179","author":"O\u2018Connell","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0610","doi-asserted-by":"crossref","first-page":"e1002258","DOI":"10.1371\/journal.ppat.1002258","article-title":"Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector","volume":"7","author":"Wang","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0615","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.vaccine.2010.12.024","article-title":"Induction of immune memory by a multisubunit chlamydial vaccine","volume":"29","author":"Eko","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0620","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1016\/j.vaccine.2009.02.095","article-title":"A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice","volume":"27","author":"Wang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0625","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1016\/j.vaccine.2012.01.017","article-title":"High-throughput proteomic screening identifies Chlamydia trachomatis antigens that are capable of eliciting T cell and antibody responses that provide protection against vaginal challenge","volume":"30","author":"Picard","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0630","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1016\/j.vaccine.2012.02.044","article-title":"Protection of pigs against genital Chlamydia trachomatis challenge by parenteral or mucosal DNA immunization","volume":"30","author":"Schautteet","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0635","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1128\/IAI.62.12.5491-5497.1994","article-title":"Humoral immune response to plasmid protein Pgp3 in patients with Chlamydia trachomatis infection","volume":"62","author":"Comanducci","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0640","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/j.vaccine.2009.12.020","article-title":"Identification of immunodominant antigens of Chlamydia trachomatis using proteome microarrays","volume":"28","author":"Molina","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0645","doi-asserted-by":"crossref","first-page":"9969","DOI":"10.1073\/pnas.1101756108","article-title":"Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines","volume":"108","author":"Finco","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0650","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1574-695X.2008.00527.x","article-title":"Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis","volume":"55","author":"Coler","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0655","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1128\/IAI.00344-09","article-title":"CT043, a protective antigen that induces a CD4+ Th1 response during Chlamydia trachomatis infection in mice and humans","volume":"77","author":"Meoni","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0660","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1086\/528378","article-title":"Antigenic profiling of a Chlamydia trachomatis gene-expression library","volume":"197","author":"Follmann","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0665","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/1521-4141(200105)31:5<1513::AID-IMMU1513>3.0.CO;2-U","article-title":"Identification of Chlamydia trachomatis antigens recognized by human CD4+ T lymphocytes by screening an expression library","volume":"31","author":"Goodall","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0670","doi-asserted-by":"crossref","first-page":"6722","DOI":"10.1128\/IAI.01119-06","article-title":"Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele","volume":"74","author":"Murthy","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0675","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.vaccine.2007.12.048","article-title":"In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB","volume":"26","author":"Barker","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0680","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2249.2007.03357.x","article-title":"Mucosal and peripheral immune responses to chlamydial heat shock proteins in women infected with Chlamydia trachomatis","volume":"148","author":"Agrawal","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2013.08.020_bib0685","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1128\/CDLI.10.1.103-107.2003","article-title":"Characterization of the humoral immune response to Chlamydia outer membrane protein 2 in chlamydial infection","volume":"10","author":"Portig","year":"2003","journal-title":"Clin Diag Lab Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13011110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13011110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T20:56:57Z","timestamp":1688417817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13011110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":137,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0264410X13011110"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development status and future prospects for a vaccine against Chlamydia trachomatis infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2013 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}